Catalyst Crew Technologies Corp. has retained securities attorney Brian Higley to serve as securities counsel to the company as it continues its strategic transition into artificial intelligence-enabled healthcare technology. Mr. Higley, who advises public companies on corporate governance, securities law compliance, regulatory matters, and capital markets activities, will assist the company with ongoing securities law compliance, regulatory filings, and other corporate legal matters.
The appointment is significant because Mr. Higley is listed on the OTC Markets website as one of only nine Premium Legal Service Providers. This designation identifies experienced securities attorneys who assist public companies with regulatory compliance, disclosure matters, and capital markets activities. For a development-stage company like Catalyst Crew Technologies, which is transitioning into a new business direction, maintaining strong governance and regulatory compliance frameworks is particularly important as it seeks to build credibility with investors and regulators.
"Maintaining strong governance and regulatory compliance is an important priority for the Company," said Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp. The engagement reflects the company's commitment to appropriate legal, governance, and regulatory compliance frameworks as it advances strategic initiatives in AI-driven healthcare technology.
Catalyst Crew Technologies is focused on developing scalable digital health solutions for emerging markets, with initial emphasis on Latin America. The company is pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. Through technology development initiatives, strategic partnerships, and targeted acquisitions, the company is building an integrated healthcare technology platform positioned to address growing demand for modernized healthcare delivery systems across emerging markets.
The appointment of premium securities counsel comes at a critical juncture for the company, which has not yet generated revenues from its newly announced business direction. As a development-stage enterprise, Catalyst Crew Technologies faces challenges including implementing its business plan, securing financing, completing acquisitions, and complying with regulatory requirements. The company's securities involve a high degree of risk, and prospective investors are urged to review all risk factors and disclosures contained in the company's filings with the U.S. Securities and Exchange Commission.
For business and technology leaders monitoring the intersection of AI and healthcare, this development highlights the importance of robust governance structures for companies navigating strategic transitions. As AI-enabled healthcare solutions gain traction in emerging markets, companies must balance innovation with regulatory compliance to build sustainable business models. The engagement of specialized legal counsel signals Catalyst Crew Technologies' recognition that successful implementation of its healthcare technology platform depends not only on technological capabilities but also on maintaining proper corporate governance and regulatory compliance frameworks.
